Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention

International Journal of Cardiology

Volumn 110, Issue 2, 2006, Pages 237-241

  Conen, David ^a,b   Buerkle, Gerd ^b   Perruchoud, André P ^a   Buettner, Heinz J ^b   Mueller, Christian ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Contrast media; Hypertension; Percutaneous transluminal coronary angioplasty; Prevention; Randomised trial; Renal failure

Indexed keywords

CONTRAST MEDIUM; CREATININE; ISOTONIC SOLUTION;

ADULT; AGED; ANAMNESIS; ANGIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; FEMALE; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME VARIABLE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CREATININE; FEMALE; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646804473     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.09.014     Document Type: Article

References (23)

1. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
2. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
3. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
4. Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
5. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., and Murray C.J. Selected major risk factors and global and regional burden of disease. Lancet 360 (2002) 1347-1360
6. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the United States renal data system 2003 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 42 (2003) A5-A7
7. Sommers S.C., Relman A.S., and Smithwick R.H. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 34 (1958) 685-715
8. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003) 2363-2369
9. Ruzyllo W., Ponikowski P., and Wilkins A. Clinical characteristics and methods of treatment of patients with stable coronary heart disease in the primary care settings-the results of the Polish, Multicentre Angina Treatment Pattern (ATP) study. Int J Clin Pract 58 (2004) 1127-1133
10. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
11. Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
12. Levey A.S. Clinical practice. Nondiabetic kidney disease. N Engl J Med 347 (2002) 1505-1511
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130 (1999) 461-470
14. Cowley Jr. A.W., Mattson D.L., Lu S., and Roman R.J. The renal medulla and hypertension. Hypertension 25 (1995) 663-673
15. Sealey J.E., Blumenfeld J.D., Bell G.M., Pecker M.S., Sommers S.C., and Laragh J.H. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens 6 (1988) 763-777
16. Mattson D.L., and Bellehumeur T.G. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension 28 (1996) 297-303
17. Keller G., Zimmer G., Mall G., Ritz E., and Amann K. Nephron number in patients with primary hypertension. N Engl J Med 348 (2003) 101-108
18. Parfrey P.S., Griffiths S.M., Barrett B.J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320 (1989) 143-149
19. Schwab S.J., Hlatky M.A., Pieper K.S., et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320 (1989) 149-153
20. Barrett B.J., Parfrey P.S., Vavasour H.M., O'Dea F., Kent G., and Stone E.A. Comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 326 (1992) 431-436
21. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
22. Boersma E., Keil U., DeBacquer D., et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 21 (2003) 1831-1840
23. Hossmann V., FitzGerald G.A., and Dollery C.T. Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension. Hypertension 3 (1981) 113-118